Advanced Search

 

Study ID Status Title Patient Level Data
SB-714703/003 Completed An open, randomised, multi-centre dose ranging phase II study to evaluate LAPDAP in combination with three different doses of artesunate
SBM20001 Completed A single centre, randomised, double-blind, double-dummy, placebo-controlled, parallel group, pilot study to determine the efficacy and safety of 2mg and 4mg doses of Ventolin ™ (salbutamol) syrup for the treatment of cough associated with acute viral upper respiratory tract infection, during a 3 ...
SBM20002 Completed A single centre, randomised, double-blind, placebo-controlled, crossover, pilot study to determine the efficacy and safety of 400 µg and 200 µg doses of Ventolin ™ salbutamol inhaler versus placebo for the treatment of smoking related cough. Study Listed on ClinicalStudyDataRequest.com
SBM40003 Completed A single centre, randomised, double blind, double dummy, cross-over study to measure the topical and systemic effects of Salbutamol delivered by the Turbuhaler inhaler compared with the Diskus dry powder inhaler at high and low flow rates in adult patients with reversible obstructive airways disease. Study Listed on ClinicalStudyDataRequest.com
SCA100223 Completed A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose, 8-Week Evaluation of the Efficacy and Safety of Lamotrigine in the Treatment of Depression in Patients with Type II Bipolar Disorder Study Listed on ClinicalStudyDataRequest.com
SCA102833 Completed The Evaluation of Lamictal as an Add-on Treatment for Bipolar I Disorder in Children and Adolescents, 10 to 17 Years of Age Study Listed on ClinicalStudyDataRequest.com
SCA104753 Completed An Open-Label Extension Study to Assess the Safety of Lamotrigine in Subjects with Bipolar Disorder, who are in remission following a manic/hypomanic index episode or a depressive index episode.
SCA104779 Completed Study SCA104779, an evaluation of BW430C (lamotrigine) versus placebo in the prevention of mood episodes in bipolar I disorder patients Study Listed on ClinicalStudyDataRequest.com
SCA106052 Completed Study SCA106052, a clinical evaluation of BW430C (lamotrigine) in bipolar I disorder– Long-term extension study (extension of study SCA104779 (NCT00550407)) Study Listed on ClinicalStudyDataRequest.com
SCA10908 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and olanzapine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA10910 Completed A randomised, partially blinded, parallel group study to investigate the potential pharmacokinetic interaction between lamotrigine and oxcarbazepine in healthy, non-smoking, male volunteers. Study Listed on ClinicalStudyDataRequest.com
SCA20022 Completed Title A Randomized, Multicenter, Double–Blind, Placebo–Controlled, Fixed–Dose, 7–Week Evaluation of the Efficacy and Safety of Lamotrigine in Patients with Major Depression
SCA20025 Completed A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose 7-Week Evaluation of theEfficacy and Safety of Lamotrigine in Treatment of a Major Depressive Episode in Unipolar DepressedPatients
SCA30905 Completed A mulitcentre, double-blind, randomised, fixed-dose evaluation of the safety and efficacy of Lamictal (lamotrigine) compared to placebo as an add-on therapy to lithium or another mood stabiliser in the treatment of bipolar depression, followed by long-term prevention of relapse and recurrence of depression and/or mania in patients with bipolar disorder
SCA30923 Completed An open, prospective study of the effectiveness of lamotrigine in the prevention of recurrence in bipolar affective disorder
SCA30924 Completed Double blind placebo controlled study of lamictal in acute bipolar depression Study Listed on ClinicalStudyDataRequest.com
SCA30926 Completed A Multi-Center, Double blind, Placebo-controlled, Randomized, Parallel Group Evaluation of the Efficacy of a Flexible Dose of Lamotrigine versus Placebo As Add-On Therapy In Schizophrenia Study Listed on ClinicalStudyDataRequest.com
SCA40910 Completed A Multicenter, Double-Blind, Placebo-Controlled, Fixed-Dose Evaluation of the Safety, Efficacy, and Tolerability of LAMICTAL (Lamotrigine) in the Treatment of a Major Depressive Episode in Patients with Type I Bipolar Disorder Study Listed on ClinicalStudyDataRequest.com
SCA40917 Completed Lamictal for use in treatment of Bipolar Disorder In Adults. A Practical Clinical Assessment of Tolerability and Clinical Effectiveness. Study Listed on ClinicalStudyDataRequest.com
SCAA1001 Completed A Randomized, Crossover Study to Evaluate the Pharmacokinetic Effect of Multiple Doses of Bupropion Hydrochloride (WELLBUTRIN SR) on a Single Oral Dose of Lamotrigine (LAMICTAL)
SCAA2008 Completed A 3 Week Multicenter, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of LAMICTAL (lamotrigine) Compared to Placebo in the Treatment of An Acute Manic or Mixed Episode in Patients who have Bipolar Disorder
SCAA2010 Completed A Multicenter, Double–Blind, Placebo–Controlled, Flexible Dose (100–400mg) 10 Week EvaluationOf the Safety and Efficacy of LAMICTAL (Lamotrigine) in the Treatment of a Major Depressive Episode inPatients with Bipolar Disorder
SCAA2011 Completed SCAA2011 (105-613): An Eight Week, Multicenter, Double-Blind, Randomized, Fixed-Dose Evaluation of the Efficacy and Safety of Lamotrigine (200mg/day), Desipramine (200mg/day), and Placebo in Outpatients with Unipolar Depression
SCAA2012 Completed A Multicenter, Double-Blind, Placebo-Controlled, Flexible-Dose, Parallel-Group Evaluation of the Safety and Efficacy of Lamotrigine in the Long-Term Prevention of Mood Episodes in Patients with Bipolar Disorder with Rapid Cycling
SCAA2014 Completed SCAA2014: A 52 Week, Open, Multicenter, Flexible-Dose Continuation Study of LAMICTAL (lamotrigine) in Patients with Bipolar Disorder Who Have Completed Protocol SCAA2010

 

 

For more information on this register please email GSKClinicalSupportHD@gsk.com

GSK-sponsored clinical studies are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.
GSK-sponsored clinical trials are those for which GSK is ultimately responsible for all aspects of the study even if some or all of these activities are transferred to another party.

ClinicalTrial.gov is a database that provides summary protocol information for ongoing clinical trials.

IFPMA.org is a search portal provided by the International Federation of Pharamceutical Manufacturers & Associations (IFPMA).

This portal provides a single entry point to search for industry sponsored clinical trials which are on existing registers and databases.

EU Clinical Trials Register is a database of all clinical trials commencing in the European Community from 1 May 2004 onwards. It has been established in accordance with Directive 2001/20/EC.